Kane Biotech Inc. (TSXV: KNE)

Kane Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	16	11	11	18	15	14
Market Cap Growth	76.90%	-6.12%	-36.87%	17.03%	6.98%	108.74%
Enterprise Value	17	20	19	23	17	15
Last Close Price	0.12	0.08	0.09	0.15	0.14	0.14
PS Ratio	19.86	70.80	71.68	11.07	11.33	8.39
PB Ratio	-27.54	-1.25	-2.72	-11.36	14.15	16.99
P/TBV Ratio	-	-	-	-	-	202.14
EV/Sales Ratio	22.72	136.28	121.77	14.60	12.97	8.83
Debt / Equity Ratio	-3.32	-1.10	-1.66	-3.01	2.11	0.25
Asset Turnover	0.16	0.03	0.03	0.29	0.34	0.79
Inventory Turnover	0.38	0.08	0.07	2.10	1.54	2.38
Quick Ratio	0.51	0.08	0.34	0.47	0.73	0.89
Current Ratio	0.82	0.34	0.49	0.61	0.94	1.37
Return on Equity (ROE)	-	-	-	-	-402.40%	-
Return on Assets (ROA)	-58.43%	-37.06%	-36.77%	-53.91%	-67.14%	-97.90%
Return on Capital (ROIC)	-160.39%	-117.08%	-73.46%	-92.61%	-119.02%	-362.75%
Earnings Yield	32.10%	-47.73%	-34.62%	-25.87%	-24.44%	-6.75%
FCF Yield	-36.82%	-30.63%	-27.17%	-13.91%	-26.08%	-6.40%
Buyback Yield / Dilution	-14.62%	-5.32%	-7.20%	-3.67%	-31.97%	-2.73%
Total Shareholder Return	-14.62%	-5.32%	-7.20%	-3.67%	-31.97%	-2.73%

Source: S&P Capital IQ. Standard template. Financial Sources.